Global Belimumab Market Growth 2025-2031

December 2025 | 76 pages | ID: GDC4A98559FEN
LP Information

Abstracts

The global Belimumab market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Belimumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Belimumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Belimumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Belimumab players cover GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Belimumab Industry Forecast” looks at past sales and reviews total world Belimumab sales in 2024, providing a comprehensive analysis by region and market sector of projected Belimumab sales for 2025 through 2031. With Belimumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Belimumab industry.

This Insight Report provides a comprehensive analysis of the global Belimumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Belimumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Belimumab market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Belimumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Belimumab.

This report presents a comprehensive overview, market shares, and growth opportunities of Belimumab market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 400mg Injection
• 120mg Injection

Segmentation by Application:

• Hospital
• Drug Center
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• GlaxoSmithKline

Key Questions Addressed in this Report

What is the 10-year outlook for the global Belimumab market?

What factors are driving Belimumab market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Belimumab market opportunities vary by end market size?

How does Belimumab break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Belimumab Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Belimumab by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Belimumab by Country/Region, 2020, 2024 & 2031
2.2 Belimumab Segment by Type
  2.2.1 400mg Injection
  2.2.2 120mg Injection
2.3 Belimumab Sales by Type
  2.3.1 Global Belimumab Sales Market Share by Type (2020-2025)
  2.3.2 Global Belimumab Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Belimumab Sale Price by Type (2020-2025)
2.4 Belimumab Segment by Application
  2.4.1 Hospital
  2.4.2 Drug Center
  2.4.3 Clinic
  2.4.4 Others
2.5 Belimumab Sales by Application
  2.5.1 Global Belimumab Sale Market Share by Application (2020-2025)
  2.5.2 Global Belimumab Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Belimumab Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Belimumab Breakdown Data by Company
  3.1.1 Global Belimumab Annual Sales by Company (2020-2025)
  3.1.2 Global Belimumab Sales Market Share by Company (2020-2025)
3.2 Global Belimumab Annual Revenue by Company (2020-2025)
  3.2.1 Global Belimumab Revenue by Company (2020-2025)
  3.2.2 Global Belimumab Revenue Market Share by Company (2020-2025)
3.3 Global Belimumab Sale Price by Company
3.4 Key Manufacturers Belimumab Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Belimumab Product Location Distribution
  3.4.2 Players Belimumab Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR BELIMUMAB BY GEOGRAPHIC REGION

4.1 World Historic Belimumab Market Size by Geographic Region (2020-2025)
  4.1.1 Global Belimumab Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Belimumab Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Belimumab Market Size by Country/Region (2020-2025)
  4.2.1 Global Belimumab Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Belimumab Annual Revenue by Country/Region (2020-2025)
4.3 Americas Belimumab Sales Growth
4.4 APAC Belimumab Sales Growth
4.5 Europe Belimumab Sales Growth
4.6 Middle East & Africa Belimumab Sales Growth

5 AMERICAS

5.1 Americas Belimumab Sales by Country
  5.1.1 Americas Belimumab Sales by Country (2020-2025)
  5.1.2 Americas Belimumab Revenue by Country (2020-2025)
5.2 Americas Belimumab Sales by Type (2020-2025)
5.3 Americas Belimumab Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Belimumab Sales by Region
  6.1.1 APAC Belimumab Sales by Region (2020-2025)
  6.1.2 APAC Belimumab Revenue by Region (2020-2025)
6.2 APAC Belimumab Sales by Type (2020-2025)
6.3 APAC Belimumab Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Belimumab by Country
  7.1.1 Europe Belimumab Sales by Country (2020-2025)
  7.1.2 Europe Belimumab Revenue by Country (2020-2025)
7.2 Europe Belimumab Sales by Type (2020-2025)
7.3 Europe Belimumab Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Belimumab by Country
  8.1.1 Middle East & Africa Belimumab Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Belimumab Revenue by Country (2020-2025)
8.2 Middle East & Africa Belimumab Sales by Type (2020-2025)
8.3 Middle East & Africa Belimumab Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Belimumab
10.3 Manufacturing Process Analysis of Belimumab
10.4 Industry Chain Structure of Belimumab

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Belimumab Distributors
11.3 Belimumab Customer

12 WORLD FORECAST REVIEW FOR BELIMUMAB BY GEOGRAPHIC REGION

12.1 Global Belimumab Market Size Forecast by Region
  12.1.1 Global Belimumab Forecast by Region (2026-2031)
  12.1.2 Global Belimumab Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Belimumab Forecast by Type (2026-2031)
12.7 Global Belimumab Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 GlaxoSmithKline
  13.1.1 GlaxoSmithKline Company Information
  13.1.2 GlaxoSmithKline Belimumab Product Portfolios and Specifications
  13.1.3 GlaxoSmithKline Belimumab Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 GlaxoSmithKline Main Business Overview
  13.1.5 GlaxoSmithKline Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Belimumab Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Belimumab Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 400mg Injection
Table 4. Major Players of 120mg Injection
Table 5. Global Belimumab Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Belimumab Sales Market Share by Type (2020-2025)
Table 7. Global Belimumab Revenue by Type (2020-2025) & ($ million)
Table 8. Global Belimumab Revenue Market Share by Type (2020-2025)
Table 9. Global Belimumab Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Belimumab Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Belimumab Sale Market Share by Application (2020-2025)
Table 12. Global Belimumab Revenue by Application (2020-2025) & ($ million)
Table 13. Global Belimumab Revenue Market Share by Application (2020-2025)
Table 14. Global Belimumab Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Belimumab Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Belimumab Sales Market Share by Company (2020-2025)
Table 17. Global Belimumab Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Belimumab Revenue Market Share by Company (2020-2025)
Table 19. Global Belimumab Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Belimumab Producing Area Distribution and Sales Area
Table 21. Players Belimumab Products Offered
Table 22. Belimumab Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Belimumab Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Belimumab Sales Market Share Geographic Region (2020-2025)
Table 27. Global Belimumab Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Belimumab Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Belimumab Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Belimumab Sales Market Share by Country/Region (2020-2025)
Table 31. Global Belimumab Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Belimumab Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Belimumab Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Belimumab Sales Market Share by Country (2020-2025)
Table 35. Americas Belimumab Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Belimumab Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Belimumab Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Belimumab Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Belimumab Sales Market Share by Region (2020-2025)
Table 40. APAC Belimumab Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Belimumab Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Belimumab Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Belimumab Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Belimumab Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Belimumab Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Belimumab Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Belimumab Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Belimumab Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Belimumab Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Belimumab Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Belimumab
Table 52. Key Market Challenges & Risks of Belimumab
Table 53. Key Industry Trends of Belimumab
Table 54. Belimumab Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Belimumab Distributors List
Table 57. Belimumab Customer List
Table 58. Global Belimumab Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Belimumab Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Belimumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Belimumab Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Belimumab Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Belimumab Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Belimumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Belimumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Belimumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Belimumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Belimumab Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Belimumab Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Belimumab Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Belimumab Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. GlaxoSmithKline Basic Information, Belimumab Manufacturing Base, Sales Area and Its Competitors
Table 73. GlaxoSmithKline Belimumab Product Portfolios and Specifications
Table 74. GlaxoSmithKline Belimumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. GlaxoSmithKline Main Business
Table 76. GlaxoSmithKline Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Belimumab
Figure 2. Belimumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Belimumab Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Belimumab Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Belimumab Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Belimumab Sales Market Share by Country/Region (2024)
Figure 10. Belimumab Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 400mg Injection
Figure 12. Product Picture of 120mg Injection
Figure 13. Global Belimumab Sales Market Share by Type in 2025
Figure 14. Global Belimumab Revenue Market Share by Type (2020-2025)
Figure 15. Belimumab Consumed in Hospital
Figure 16. Global Belimumab Market: Hospital (2020-2025) & (K Pcs)
Figure 17. Belimumab Consumed in Drug Center
Figure 18. Global Belimumab Market: Drug Center (2020-2025) & (K Pcs)
Figure 19. Belimumab Consumed in Clinic
Figure 20. Global Belimumab Market: Clinic (2020-2025) & (K Pcs)
Figure 21. Belimumab Consumed in Others
Figure 22. Global Belimumab Market: Others (2020-2025) & (K Pcs)
Figure 23. Global Belimumab Sale Market Share by Application (2024)
Figure 24. Global Belimumab Revenue Market Share by Application in 2025
Figure 25. Belimumab Sales by Company in 2025 (K Pcs)
Figure 26. Global Belimumab Sales Market Share by Company in 2025
Figure 27. Belimumab Revenue by Company in 2025 ($ millions)
Figure 28. Global Belimumab Revenue Market Share by Company in 2025
Figure 29. Global Belimumab Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Belimumab Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Belimumab Sales 2020-2025 (K Pcs)
Figure 32. Americas Belimumab Revenue 2020-2025 ($ millions)
Figure 33. APAC Belimumab Sales 2020-2025 (K Pcs)
Figure 34. APAC Belimumab Revenue 2020-2025 ($ millions)
Figure 35. Europe Belimumab Sales 2020-2025 (K Pcs)
Figure 36. Europe Belimumab Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Belimumab Sales 2020-2025 (K Pcs)
Figure 38. Middle East & Africa Belimumab Revenue 2020-2025 ($ millions)
Figure 39. Americas Belimumab Sales Market Share by Country in 2025
Figure 40. Americas Belimumab Revenue Market Share by Country (2020-2025)
Figure 41. Americas Belimumab Sales Market Share by Type (2020-2025)
Figure 42. Americas Belimumab Sales Market Share by Application (2020-2025)
Figure 43. United States Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Belimumab Sales Market Share by Region in 2025
Figure 48. APAC Belimumab Revenue Market Share by Region (2020-2025)
Figure 49. APAC Belimumab Sales Market Share by Type (2020-2025)
Figure 50. APAC Belimumab Sales Market Share by Application (2020-2025)
Figure 51. China Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 55. India Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Belimumab Sales Market Share by Country in 2025
Figure 59. Europe Belimumab Revenue Market Share by Country (2020-2025)
Figure 60. Europe Belimumab Sales Market Share by Type (2020-2025)
Figure 61. Europe Belimumab Sales Market Share by Application (2020-2025)
Figure 62. Germany Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 63. France Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Belimumab Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Belimumab Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Belimumab Sales Market Share by Application (2020-2025)
Figure 70. Egypt Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Belimumab Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Belimumab in 2025
Figure 76. Manufacturing Process Analysis of Belimumab
Figure 77. Industry Chain Structure of Belimumab
Figure 78. Channels of Distribution
Figure 79. Global Belimumab Sales Market Forecast by Region (2026-2031)
Figure 80. Global Belimumab Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Belimumab Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Belimumab Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Belimumab Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Belimumab Revenue Market Share Forecast by Application (2026-2031)